Insider sale reported: 31,104 shares

Form 144 filing reports insider sales by Kirk Coleman.

Rhea-AI Filing Summary

Form 144 filing reports insider sales by Kirk Coleman. The filing lists three restricted/common stock dispositions: 8,559 shares on 12/10/2025, 12,917 shares on 02/17/2026, and 7,752 shares on 03/03/2026. Each sale shows gross proceeds in the filing alongside the share counts.

Insights

Insider Transactions Expert

Routine Section 144 sales by Kirk Coleman reported across three dates.

The filing lists three dispositions with exact share counts and gross proceeds: 8,559 shares for 630,627.12 on 12/10/2025, 12,917 shares for 68,757.91 on 02/17/2026, and 7,752 shares for 385,445.37 on 03/03/2026.

These entries appear as standard 144 disclosures. Timing, method of sale, and any broker or plan details are not provided in the excerpt; subsequent filings may provide additional execution detail.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions does the QTWO Form 144 disclose?

The Form 144 discloses three insider sales by Kirk Coleman across three dates. It lists 8,559 shares on 12/10/2025, 12,917 shares on 02/17/2026, and 7,752 shares on 03/03/2026, each with the filing's reported gross proceeds.

Who is the reporting person on the Form 144 for QTWO?

The filing identifies Kirk Coleman as the reporting person. His name and address are shown alongside the three separate common stock dispositions dated 12/10/2025, 02/17/2026, and 03/03/2026.

What gross proceeds are shown for each sale in the filing?

The filing shows gross proceeds for each listed sale: 630,627.12 for 8,559 shares on 12/10/2025, 68,757.91 for 12,917 shares on 02/17/2026, and 385,445.37 for 7,752 shares on 03/03/2026.

Do the Form 144 entries specify the sale method or broker?

No; the excerpt lists share counts, dates, and gross proceeds but does not state sale methods or broker details. The filing shows restricted/RSU/PSU references, but execution mechanics are not included in the provided text.

Does the filing indicate shares to be sold or remaining authorization?

The excerpt lists specific past sales and a line showing 31,104 in a securities field, but it does not present clear language about additional shares being offered or remaining authorization; the filing's precise intent beyond the listed dispositions is not detailed in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 08:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001957145
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Q2 Holdings, Inc.
SEC File Number	001-36350
Address of Issuer	10355 PECAN PARK BOULEVARD Austin TEXAS 78729
Phone	1-833-444-3469
Name of Person for Whose Account the Securities are To Be Sold	Coleman Kirk L
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley 1585 Boardway New York NY 10036	31104	1547518.00	262657	03/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2026	Restricted Stock Units/Performance Stock Units	Issuer			31104	03/04/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kirk Coleman 10355 Pecan Park Blvd. Austin TX 78729	Common	12/10/2025	8559	630627.12
Kirk Coleman 10355 Pecan Park Blvd Austin TX 78729	Common	02/17/2026	12917	68757.91
Kirk Coleman 10355 Pecan Park Blvd. Austin TX 78729	Common	03/03/2026	7752	385445.37

144: Remarks and Signature

Remarks	The sale reported on this Form 144 represents an Issuer mandated sale by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and Performance Stock Units, and it does not represent a discretionary trade by the Reporting Person.
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael S Kerr as Attorney-in-fact for Kirk Coleman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)